These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 32504312)

  • 21. Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice.
    MacPherson KP; Sompol P; Kannarkat GT; Chang J; Sniffen L; Wildner ME; Norris CM; Tansey MG
    Neurobiol Dis; 2017 Jun; 102():81-95. PubMed ID: 28237313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzo(a)pyrene exposure induced neuronal loss, plaque deposition, and cognitive decline in APP/PS1 mice.
    Liu D; Zhao Y; Qi Y; Gao Y; Tu D; Wang Y; Gao HM; Zhou H
    J Neuroinflammation; 2020 Aug; 17(1):258. PubMed ID: 32867800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice.
    Kaya I; Jennische E; Lange S; Tarik Baykal A; Malmberg P; Fletcher JS
    J Neurochem; 2020 Jul; 154(1):84-98. PubMed ID: 32141089
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caspase-6 Knockout in the 5xFAD Model of Alzheimer's Disease Reveals Favorable Outcome on Memory and Neurological Hallmarks.
    Angel A; Volkman R; Royal TG; Offen D
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of neuroinflammation and pathology in the 5XFAD mouse model of Alzheimer's disease using a biased and selective beta-1 adrenergic receptor partial agonist.
    Ardestani PM; Evans AK; Yi B; Nguyen T; Coutellier L; Shamloo M
    Neuropharmacology; 2017 Apr; 116():371-386. PubMed ID: 28089846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model.
    Cai M; Lee JH; Yang EJ
    J Neuroinflammation; 2019 Dec; 16(1):264. PubMed ID: 31836020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2.
    Gutiérrez IL; González-Prieto M; Caso JR; García-Bueno B; Leza JC; Madrigal JLM
    Mol Neurobiol; 2019 Dec; 56(12):8628-8642. PubMed ID: 31297718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glia Maturation Factor and Mitochondrial Uncoupling Proteins 2 and 4 Expression in the Temporal Cortex of Alzheimer's Disease Brain.
    Thangavel R; Kempuraj D; Zaheer S; Raikwar S; Ahmed ME; Selvakumar GP; Iyer SS; Zaheer A
    Front Aging Neurosci; 2017; 9():150. PubMed ID: 28572767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gad67 haploinsufficiency reduces amyloid pathology and rescues olfactory memory deficits in a mouse model of Alzheimer's disease.
    Wang Y; Wu Z; Bai YT; Wu GY; Chen G
    Mol Neurodegener; 2017 Oct; 12(1):73. PubMed ID: 29017573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LPS priming before plaque deposition impedes microglial activation and restrains Aβ pathology in the 5xFAD mouse model of Alzheimer's disease.
    Yang Y; García-Cruzado M; Zeng H; Camprubí-Ferrer L; Bahatyrevich-Kharitonik B; Bachiller S; Deierborg T
    Brain Behav Immun; 2023 Oct; 113():228-247. PubMed ID: 37437821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (-)-Oleocanthal Nutraceuticals for Alzheimer's Disease Amyloid Pathology: Novel Oral Formulations, Therapeutic, and Molecular Insights in 5xFAD Transgenic Mice Model.
    Tajmim A; Cuevas-Ocampo AK; Siddique AB; Qusa MH; King JA; Abdelwahed KS; Sonju JJ; El Sayed KA
    Nutrients; 2021 May; 13(5):. PubMed ID: 34069842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease.
    Mirzaei N; Mota BC; Birch AM; Davis N; Romero-Molina C; Katsouri L; Palmer EOC; Golbano A; Riggall LJ; Nagy I; Tyacke R; Nutt DJ; Sastre M
    Br J Pharmacol; 2021 Feb; 178(3):654-671. PubMed ID: 33140839
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subchronic administration of auranofin reduced amyloid-β plaque pathology in a transgenic APP
    Upīte J; Kadish I; van Groen T; Jansone B
    Brain Res; 2020 Nov; 1746():147022. PubMed ID: 32707043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellulose ether treatment inhibits amyloid beta aggregation, neuroinflammation and cognitive deficits in transgenic mouse model of Alzheimer's disease.
    Ali T; Klein AN; McDonald K; Johansson L; Mukherjee PG; Hallbeck M; Doh-Ura K; Schatzl HM; Gilch S
    J Neuroinflammation; 2023 Jul; 20(1):177. PubMed ID: 37507761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
    Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
    J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo.
    Bai Y; Ma X
    Int Immunopharmacol; 2020 Nov; 88():106790. PubMed ID: 32795892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diesel engine exhaust accelerates plaque formation in a mouse model of Alzheimer's disease.
    Hullmann M; Albrecht C; van Berlo D; Gerlofs-Nijland ME; Wahle T; Boots AW; Krutmann J; Cassee FR; Bayer TA; Schins RPF
    Part Fibre Toxicol; 2017 Aug; 14(1):35. PubMed ID: 28854940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.
    Oakley H; Cole SL; Logan S; Maus E; Shao P; Craft J; Guillozet-Bongaarts A; Ohno M; Disterhoft J; Van Eldik L; Berry R; Vassar R
    J Neurosci; 2006 Oct; 26(40):10129-40. PubMed ID: 17021169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-IL17 treatment ameliorates Down syndrome phenotypes in mice.
    Rueda N; Vidal V; García-Cerro S; Narcís JO; Llorens-Martín M; Corrales A; Lantigua S; Iglesias M; Merino J; Merino R; Martínez-Cué C
    Brain Behav Immun; 2018 Oct; 73():235-251. PubMed ID: 29758264
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
    Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.